(1 - 13 von 28
)
Genzyme open to Campath clause in Sanofi bid: report
www.reuters.com
[Reuters] - Termeer added that he met Sanofi Chief Executive Officer Chris Viehbacher regularly at industry events, where relations were "courteous" and the two did not
Une solution en vue pour réconcilier Sanofi et Genzyme
www.lesechos.fr
[Les Échos] - Genzyme anticipe un pic de ventes à 3 milliards de dollars, des chiffres qui, selon le directeur général de Sanofi Chris Viehbacher, « font sourire tout le
Genzyme Wait for Higher Bid Risky Due to FDA Plant Deadline, Orbimed Says
www.bloomberg.com
[Bloomberg] - Chris Viehbacher, Sanofi's chief executive officer, has visited OrbiMed's offices twice since the takeover bid, said Hsu. “He's pretty committed to the deal
Google News: Matices: Sanofi-Aventis y Genzyme prosiguen su cortejo
[El Global] - Cuando aún no han pasado dos años desde que Chris Viehbacher se hizo con el timón de Sanofi-Aventis, hasta la fecha se han invertido unos millones de
sortiert nach Relevanz / Datum